New study at a single dose Zynamite®
Zynamite® clinical trial demonstrates sustained effect on brain functions from a single dose. One dose of Zynamite® is enough to significantly improve performance in a range of cognitive tasks including enhanced attention and memory, reports new clinical data.
Double-blind, placebo-controlled cross-over design with 70 healthy women and men aged 18 to 45
Each received a single dose of 300mg Zynamite® and a matched placebo (on separate occasions)
A battery of cognitive tests were performed pre-dose, at 30 minutes, 3 hours, and 5 hours post dose
Significant improvement performance accuracy of Computerised Mental Performance Assessment System (COMPASS) assessment battery, including enhanced performance in the Attention and Memory assessments.
Effects were sustained throughout the study – from 30 minutes after dose to 5 hours post dose